NK cell and PD-1 antibody
19K047-001
Phase 2 other completed
Quick answer
NK cell and PD-1 antibody for Non-small Cell Lung Cancer is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Non-small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- other
- Status
- completed